联系方式

Dr. Gregor Schmid, LL.M. (Cambridge)

合伙人

Read More

Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

授薪合伙人

Read More

Dr. Jens Wolf

合伙人

Read More

Philipp Hoegl

授薪合伙人

Read More

Philipp Bergjans

律师

Read More

Dr. Stefanie Greifeneder

合伙人

Read More

Dr. Andrea Sautter

授薪合伙人

Read More

Sherin Sayed

律师

Read More

Nico Jänicke

合伙人

Read More

Jan-Mathias Pfleging

高级律师

Read More

Thanos Rammos, LL.M.

合伙人

Read More

Hazal Viola Koepp-Strand, LL.M. (Lund)

律师

Read More

Dr. Eva Surowiecki, LL.B. (London)

高级律师

Read More
联系方式

Dr. Gregor Schmid, LL.M. (Cambridge)

合伙人

Read More

Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

授薪合伙人

Read More

Dr. Jens Wolf

合伙人

Read More

Philipp Hoegl

授薪合伙人

Read More

Philipp Bergjans

律师

Read More

Dr. Stefanie Greifeneder

合伙人

Read More

Dr. Andrea Sautter

授薪合伙人

Read More

Sherin Sayed

律师

Read More

Nico Jänicke

合伙人

Read More

Jan-Mathias Pfleging

高级律师

Read More

Thanos Rammos, LL.M.

合伙人

Read More

Hazal Viola Koepp-Strand, LL.M. (Lund)

律师

Read More

Dr. Eva Surowiecki, LL.B. (London)

高级律师

Read More

2024年2月27日

Bertelsmann Investments acquires pharma tech company EXTEDO with Taylor Wessing

Bertelsmann Investments acquires the pharmaceutical technology company EXTEDO for a double-digit million amount. A Taylor Wessing team led by the two partners Dr Gregor Schmid (Berlin) and Dr Niclas von Woedtke (Hamburg) advised Bertelsmann Investments on all legal issues in connection with the acquisition.

Bertelsmann Investments is the investment arm of Bertelsmann and has invested around €1.7 billion in over 400 innovative companies and funds to date. The venture capital company currently holds shares in more than 360 innovative companies and funds, particularly in the fields of education, digital media, fintech, e-commerce and adtech. The acquisition of EXTEDO expands Bertelsmann Investments' portfolio of companies with the aim of strategically expanding its position in the European growth market of pharma tech through synergies with existing portfolio companies. As a leading provider of software solutions and services in the field of regulatory information, EXTEDO brings extensive expertise to the table, which both industry customers and public authorities can draw on.

EXTEDO's customers include around 1,000 pharmaceutical companies and public institutions in more than 65 countries, including 35 regulatory authorities, which use the pharma tech service provider's solutions to optimise their regulatory business processes in the areas of document management, product registration, approval management and drug safety.

Legal advisors Bertelsmann Investments
Taylor Wessing Germany:
Jointly led by Dr Gregor Schmid (Partner, IP / IT / Data Law, Berlin) and Dr Niclas von Woedtke (Salary Partner, Corporate/M&A, Hamburg); Dr Jens Wolf (Partner), Philipp Hoegl (Salary Partner), Philipp Bergjans (Associate), all M&A/Venture Capital, all Hamburg; Dr Stefanie Greifeneder (Partner), Dr Andrea Sautter (Salary Partner), Sherin Sayed (Associate), all Patents Technology & Life Sciences, all Munich; Nico Jänicke (Partner), Jan-Mathias Pfleging (Senior Associate), Alois Lobkowicz (Associate), all Employment, Pensions & Mobility, all Berlin; Thanos Rammos (Partner), Hazal Viola Koepp-Strand (Associate), Dr. Eva Surowiecki, LL.B. (Associate), all IP/IT and Data Law, all Berlin

In-house Bertelsmann Investments: Dr Martin Dannhoff (lead)
Legal advisor to the seller: Dornbach RAe
 
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

公司/并购与资本市场

Healthcare & Life Sciences: Taylor Wessing advises Protembis GmbH on Series B financing round

2024年3月27日

作者

点击此处了解更多
公司/并购与资本市场

Taylor Wessing advises Azenta Life Sciences on the acquisition of the Barkey Group

2022年6月17日

作者

点击此处了解更多
公司/并购与资本市场

Taylor Wessing advises Formycon on acquisition of biosimilar assets in strategic partnership with ATHOS

2022年3月31日

作者

点击此处了解更多